Annual General Meeting of Q-Cells AG prepares the ground for further
fast growth
- Possibility of option and/or convertible bonds of up to ¤ 5 billion
- Resolution for change of legal form to a European company (Q-Cells
SE) passed
Bitterfeld-Wolfen/Leipzig (Germany) - 26 June 2008. The Annual
General Meeting of Q-Cells AG today (Thursday) adopted all of the
presented items on the agenda by a large majority. In addition to
approving retention of all the net income for 2007 to strengthen the
capital base and fund further growth, the shareholders agreed to a
possible raising of option and/or convertible bonds in the aggregate
principal amount of up to ¤ 5 billion.
The Annual General Meeting also approved the merger between Q-Cells
AG and Q-Cells Österreich AG and to change the company's legal form
into a European Company (SE). Since the relevant employee agreement
has already been concluded and the merger plan notarised, the change
of legal form will take effect with registration with the commercial
register. The Annual General Meeting also granted approval of the
actions of the Executive Board members and Supervisory Board members
for fiscal year 2007.
Additional information:
Q-Cells AG
Stefan Lissner
Head of Investor Relations
Guardianstraße 16
06766 Bitterfeld-Wolfen
Germany
investor@q-cells.com
Tel.: +49 - (0)3494 - 6699 10101
